In a prospective study of HR+/HER2− metastatic breast cancer treated with a CDK4/6is plus endocrine therapy, circulating Treg cells and myeloid-derived suppressor cells decreased significantly, while CD4+T cells and cytotoxic CD8+T cells with anti-tumor phenotype increased [144]. The gene discussed is CD4; the disease is neoplasm.